# Cizzle Biotechnology New Research Agreement with the University of York for Cancer Tests

- Link: https://www.directorstalkinterviews.com/cizzle-biotechnology-new-research-agreement-with-the-university-of-york-for-cancer-tests/4121022923
- Published: 2021-09-17T07:04:19+01:00
- Author: Giles

**Cizzle Biotechnology Holdings plc** (LON:CIZ), the UK based diagnostics developer,
is pleased to announce that it has entered into a new research agreement with the
University of York for the development and validation of molecular tools with potential
applications in cancer diagnosis and therapy.

The Company’s wholly owned subsidiary Cizzle Biotechnology Limited was a spin out
from the University of York based on original research and development undertaken
in laboratories at the University, under the direction of Professor Dawn Coverley.
The new agreement extends that relationship and provides seconded staff and access
to the University’s state of the art research facilities to support reagent generation
work in collaboration with our recently announced Contract Research Organisation(
CRO) partner Fairjouney Biologics.

> **Commenting, Allan Syms, Executive Chairman of Cizzle Biotechnology, said:** “
> We are thrilled to be able to cement our long-standing relationship with the University
> of York, a member of the Russell Group of research-intensive universities and 
> one of the world’s premier institutions for inspirational and life-changing research.
> This new agreement will provide valuable additional resource and capability for
> developing our blood test for the early detection of lung cancer, and potentially
> other forms of cancer.”

Share on: